Navigation Links
Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
Date:9/6/2007

A new study has found an unexpected number of viruses and viral subtypes in patients with respiratory tract infections (RTIs). The technique used in the study may help identify new viruses associated with human diseases. The study is published in the September 15 issue of The Journal of Infectious Diseases, now available online.

RTIs, such as the common cold, are associated with some of the most common viral infections, and increase the risk of an asthma attack in those with the condition. Fifty to 80 percent of asthma exacerbations are precipitated by viral upper RTIs, and yet these viruses are still poorly understood.

The Virochip technique, a DNA microarray or genome chip developed by researchers at the University of California, San Francisco, uses the most conserved sequences of all known viruses of humans, animals, plants, and microbes for its detection system. The new study is the first to employ this strategy to investigate the viruses associated with RTIs in people with and without asthma.

The study, conducted by Amy Kistler, PhD, and colleagues in California, Illinois, and Missouri, used several methods to test 53 asthmatic and 30 non-asthmatic adults for viruses at various stages of health. Compared to the conventional methods of viral culture and the highly sensitive polymerase chain reaction (PCR) method, the Virochip had excellent agreement in terms of identifying viral pathogens, and proved to be both highly sensitive and specific.

The method detected remarkable and unanticipated diversity of viruses linked with RTIs and identified a wholly new branch of the phylogenetic tree, for the human rhinovirus, one of the causative agents of the common cold virus, Dr. Kistler notes, showing that even with a small test group the Virochip enabled detection of new viruses that were not possible to culture. The researchers also detected 30 distinct known species of rhinoviruses and found that only one of the two co
'/>"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel antibiotic dressing developed for improved wound healing
3. A novel augmentation
4. Novel biopsy technique for prostate cancer
5. Novel computer model for breast cancer
6. Novel research on liver cancer
7. Novel way to fight cancer
8. Novel test for bowel cancer
9. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
10. Novel Therapy for Chronic Problem
11. Gene enchances radiation therapy - A novel approach to fight cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...YHILL,N.J.,Nov.23/PRNewswire/--InasurveyofNewJerse...hiefFinancialOfficers,72percentdonotbelieveanewhea...tem. ,, Accordingtoresultsofthelatestsurveycond...untingfirm,theeconomytoppedthelistat85percentasthe...sestoits1500surveyssenttocompaniesfromallpartsofNe...
(Date:11/23/2009)...J. The Center for Science Writings at Stevens Ins...f God," a talk by Robert Wright, journalist and fo...09, 4:00-5:30 p.m. at the Babbio Center for Techno...pen to the public and the media., In his new boo...st Robert Wright, renowned for his popular works o...
(Date:11/23/2009)...Minn. -- Major medical errors self-reported by Ame...t and depression. Those findings appear today in t... Clinic-led study included collaborators from John..., In the confidential study, nearly 9 percent o...error in the three months prior to being surveyed....
(Date:11/23/2009)...N, Va. The Infectious Diseases Society of America...administration and the European Union to further t... 10 new antibiotics within the next 10 years, know...ganization (WHO) has identified antimicrobial resi...an health. , A new European Union report confirm...
(Date:11/23/2009)...in home-based settings get far more screen time t... , MONDAY, Nov. 23 (HealthDay News) --Young c...evision every day than previous reports have found... a new study finds. , Researchers from Seattle ...on surveyed day-care directors to find out how muc...
Breaking Medicine News(10 mins):Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:Day Care Boosts Kids' TV Time 2Health News:Day Care Boosts Kids' TV Time 3
...iefu, vice minister of health in China has sought ... demand of organs by patients in their country//. ...ed for organ donations and the actual donations. ...onated by people after signing voluntary agreement...
...ng to a research conducted by Dr Michael Kisley, a...he US, older people have a more positive// outlook...e reported in the journal Psychological Science. ...ative aspects of life. The viewing was restricted ...
...nation of AZT, lamivudine, and nevirapine (AZT/3TC...e month after delivery resulted in significantly r...the HIV levels found in the breast milk of women w...s pilot study to examine the effect of using tripl...
...utes, perversions and public scandals – the stuff ...rs three centuries earlier,// according to new res...ing of erotic literature was already a social acti...tury Britain: "I tried to get a grip on just how m...
... has been declared free of neonatal tetanus by the... Kartar Devi said Saturday that a communication ha... welfare ministry, declaring that neonatal tetanus... a survey conducted by the central ministry on bir...
...s with arterial disease have relatively high rates...eart attack, stroke or //cardiovascular death) wit...f arterial locations afflicted, according to a stu...AD; narrowing of the arteries that supply the legs...
Other Medicine News:Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 2Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 3Health News:Triple ARV Prophylaxis Reduces Viral Load in Breast Milk 4Health News:Sex – Three Hundred Years Ag 2Health News:Sex – Three Hundred Years Ag 3Health News:Atherothrombosis Associated With High Rates of Cardiovascular Events 2
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Reportlinker.comanno...atalogue. ,, HolterMonitoringSystems-AGlobalMa...164324/Holter-Monitoring-Systems---A-Global-Market...pr&utm_campaign=prnewswire ,, Cardiovas...ents.High-riskpatientsneedtobecontinuouslymonitore...
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Reportlinker.comanno...atalogue. ,, AnesthesiaDisposables-AWorldMarke...276/Anesthesia-Disposables---A-World-Market-Review...utm_campaign=prnewswire ,, Globalgeneralane...eeofsaturation.Despitetheconsiderablerisewitnessed...
(Date:11/23/2009)..., BIRMINGHAM,Ala.andNOIDA,India,Nov.23/PRNewswire-...amaatBirmingham(UAB),andSouthernResearchInstitutet...gtheircollectiveinnovationandenablingtechnologiesi...iseases.ItisauniqueU.S.-Indiaarbitragedandleverage...rdabletherapiesforpatientsworldwide.AMemorandumofU...
Breaking Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 1OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 2OTCBB WNDM Announces Activation of BioPharma Division to Solicit Technology and Development Partners 61141 3Biotechnology Salutes Americas Veterans 3B Innovations Continue to Offer Improved Treatment and Care of Combat Troops 6171 1Biotechnology Salutes Americas Veterans 3B Innovations Continue to Offer Improved Treatment and Care of Combat Troops 6171 2WellTek MedX Group Completes Major Reorganization 6168 1WellTek MedX Group Completes Major Reorganization 6168 2
...e Francophone du Myelome (IFM),Trial Presented Dur...wire-FirstCall/ --,Millennium Pharmaceuticals, Inc...he comparative Phase III clinical trial evaluating...le myeloma (MM),patients. As induction therapy pri... based therapy produced a high complete remission,...
.../PRNewswire/ -- Portola,Pharmaceuticals, Inc. anno...linical data on its oral Factor Xa inhibitor and o... at the XXI Congress of,the International Society ...itzerland on July 6 through July 12, 2007. , The E...Company,s,lead compound PRT054021, is entitled "Ev...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Portola Pharmaceuticals Announces Positive Phase II EXPERT Results,and Additional Oral and Poster Presentations at the XXI Congress of,the International Society on Thrombosis and Haemostasis (ISTH) 2Portola Pharmaceuticals Announces Positive Phase II EXPERT Results,and Additional Oral and Poster Presentations at the XXI Congress of,the International Society on Thrombosis and Haemostasis (ISTH) 3
GENIE BLOTTER
The Panther Semi-dry Electroblotter - Model HEP-3 (Complete System)
Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell
...inated DNA and RNA from agarose gels to hybridizat...s speed and efficiency of transfer by allowing hig...ated system allowing electrophoresis, gel treatmen...us 29 hours required for conventional methods ,Pos...
Medicine Products: